What data do we need to diagnose and treat obstructive sleep apnoea syndrome?

Sleep Medicine Reviews

Volumn 6, Issue 1, 2002, Pages 3-6

  Kryger, Meir ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AROUSAL; DISEASE SEVERITY; EDITORIAL; HUMAN; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; RISK FACTOR; SLEEP APNEA SYNDROME; SOMNOLENCE; SYMPTOMATOLOGY;

EID: 0036462796     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1053/smrv.2001.0222     Document Type: Editorial

References (28)

1. Lindberg E, Gislason T. Epidemiology of sleep-related breathing disorders. Sleep Med Rev.
2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-1235.
3. Garcia Rio F, Racionero MA, Pino JM, Martinez I, Ortuno F, Villasante C, Villamor J. Sleep apnoea and hypertension. Chest 2000; 117: 1417-1425.
4. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-1384.
5. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, et al. Association of sleep-disordered breathing, sleep apnoea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283: 1829-1836.
6. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: Population study. BMJ 2000; 320: 479-482.
7. Brooks D, Horner RL, Kozar LF, Render Teixeira CL, Phillipson EA. Obstructive sleep apnoea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997; 99: 106-109.
8. Decary A, Rouleau I, Montplaisir J. Cognitive deficits associated with sleep apnoea syndrome: A proposed neuropsychological test battery. Sleep 2000; 23: 369-381.
9. Lojander J, Kajaste S, Maasilta P, Partinen M. Cognitive function and treatment of obstructive sleep apnoea syndrome. J Sleep Res 1999; 8: 71-76.
10. Juniper M, Hack MA, George CF, Davies RJ, Stradling JR. Steering simulation performance in patients with obstructive sleep apnoea and matched control subjects. Eur Respir J 2000; 15: 590-595.
11. Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997; 20: 608-613.
12. Yang EH, Hla KM, McHorney CA, Havighurst T, Badr MS, Weber S. Sleep apnoea and quality of life. Sleep 2000; 23: 535-541.
13. Hui DS, Chan JK, Choy DK, Ko FW, Li TS, Leung RC, Lai CK. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest 2000; 117: 1410-1416.
14. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnoea/hypopnea syndrome? Am J Respir Crit Care Med 1999; 159: 1096-1100.
15. D'Ambrosio C, Bowman T, Mohsenin V. Quality of life in patients with obstructive sleep apnoea: Effect of nasal continuous positive airway pressure - A prospective study. Chest 1999; 115:123-129.
16. Meslier N, Lebrun T, Grillier Lanoir V, Rolland N, Henderick C, Sailly JC, Racineux JL. A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 1998; 12: 185-192.
17. Bolitschek J, Schmeiser Rieder A, Schobersberger R, Rosenberger A, Kunze M, Aigner K. Impact of nasal continuous positive airway pressure treatment on quality of life in patients with obstructive sleep apnoea. Eur Respir J 1998; 11: 890-894.
18. Jenkinson C, Davies RJ, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised prospective parallel trial. Lancet 1999; 353: 2100-2105.
19. Hack M, Davies RJ, Mullins R, Choi SJ, Ramdassingh Dow S, Jenkinson C, Stradling JR. Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea. Thorax 2000; 55: 224-231.
20. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: A systematic review of the research evidence. BMJ 1997; 314: 851-860.
21. Wright J, Sheldon T. The efficacy of nasal continuous positive airway pressure in the treatment of obstructive sleep apnoea syndrome is not proven. Am J Respir Crit Care Med 2000; 161: 1776-1778.
22. Davies RJO, Stradling JR. The efficacy of nasal continuous positive airway pressure in the treatment of obstructive sleep apnoea syndrome is proven. Am J Respir Crit Care Med 2000; 161: 1775-1776.
23. Lévy P, Pépin J-L, McNicholas WT. Should all sleep apnoea patients be treated? Yes. Sleep Med Rev 2002; 6: 17-26.
24. Montserrat JM, Barbe F, Rodenstein DO. Should all sleep apnoea patients be treated? Sleep Med Rev 2002; 6: 7-14.
25. Fauci AS, Braunwald E, Isselbacher K et al. The practice of medicine. In: Fauci AS, Braunwald E, Isselbacher K et al. (eds). Harrison's The Practice of Medicine. New York: McGraw-Hill, 1998: p. 3.
26. American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689.
27. Guilleminault C, Stoohs R, Clerk A, Cetel M, Maistros P. A cause of excessive daytime sleepiness. The upper airway resistance syndrome. Chest 1993; 104: 781-787.
28. Loube DI, Gay PC, Strohl KP, Pack Al, White DP, Collop NA. Indications for positive airway pressure treatment of adult obstructive sleep apnoea patients: A consensus statement. Chest 1999; 115: 863-866.